Top Vaccines companies in Netherlands by Price to Sales Ratio (P/S)
This ranking features the top 1 Vaccines companies in Netherlands ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 33.25, for February 07, 2025.
Netherlands
Vaccines
Price to Sales Ratio (P/S)
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
33.25 |
Feb. 5, 2025 | USD 667.09 | 1.81% |
|
Netherlands |
Frequently Asked Questions
-
Which Vaccines company in Netherlands has the highest Price to Sales Ratio (P/S) ?
The Vaccines company in Netherlands with the highest Price to Sales Ratio (P/S) is argenx SE (Brussels Stock Exchange: ARGX.BR) at 33.25.
-
Which Vaccines company in Netherlands has the lowest Price to Sales Ratio (P/S) ?
The Vaccines company in Netherlands with the lowest Price to Sales Ratio (P/S) is argenx SE (Brussels Stock Exchange: ARGX.BR) at 33.25.
-
What are the top 10 Vaccines companies in Netherlands by Price to Sales Ratio (P/S) ?
The top 10 Vaccines companies in Netherlands by Price to Sales Ratio (P/S) are and argenx SE.
-
What are the bottom 10 Vaccines companies in Netherlands by Price to Sales Ratio (P/S) ?
The bottom 10 Vaccines companies in Netherlands by Price to Sales Ratio (P/S) are and argenx SE.
